PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Raymond Silcock was last confirmed as CFO at PERRIGO Co plc (PRGO) in a filing dated March 24, 2023. The proxy statement of PERRIGO Co plc reports total compensation of $3,254,588 for Raymond Silcock in fiscal 2022, including a base salary of $376,940. Disclosed compensation is on record for 4 fiscal years. Raymond Silcock has spoken on 3 earnings calls across 1 company, most recently for PERRIGO Co plc on May 11, 2022. The companies whose calls Raymond Silcock spoke on are classified in the Healthcare sector.
“And yes, this is my last Perrigo earnings call as I am going to be retiring from the company. It has been a privilege to work with the talented Perrigo team over the past 3+ years.”
“Before we begin, I want to emphasize the significant milestones that the Perrigo team achieved in 2021. These accomplishments were made possible through the dedication of our colleagues worldwide, and I sincerely thank the Perrigo team for their hard work.”
“Firstly, with respect to the major strategic initiatives completed this quarter and outlined in this morning's press release, I'd like to reiterate Murray's comments that these achievements do indeed lay the foundation for our bright future.”
Start not stated–2023-03-24
Last confirmed by a filing; no departure on record
PRGO
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | PERRIGO Co plc (PRGO) | EVP, CFO | $376,940 | $3,254,588 |
| 2021 | PERRIGO Co plc (PRGO) | EVP, CFO | $678,287 | $3,203,032 |
| 2020 | PERRIGO Co plc (PRGO) | EVP, CFO | $664,625 | $3,359,420 |
| 2019 | PERRIGO Co plc (PRGO) | Executive Vice | $500,000 | $3,480,208 |